Figure - available from: Supportive Care in Cancer
This content is subject to copyright. Terms and conditions apply.
Results of deterministic sensitivity analysis. DTX, docetaxel; FN, febrile neutropenia; ICER, incremental cost-effectiveness ratio; Peg-G, pegfilgrastim; QALY, quality-adjusted life year; RAM, ramucirumab; WTP, willingness to pay. The vertical axis represents the base-case ICER, horizontal bars represent the difference between the base-case ICER and ICER generated when the model was run using the high and low values of the plausible range, and the entire length of each horizontal bar represents the magnitude of variation in the cost-effectiveness results
Source publication
Purpose
The dose-limiting factor of ramucirumab plus docetaxel (RAM + DTX) in patients with non-small cell lung cancer (NSCLC) is febrile neutropenia (FN), which has a high incidence in Asians. This study aimed to evaluate the cost-effectiveness of pegfilgrastim (Peg-G) in patients with NSCLC receiving RAM + DTX in Japan.
Methods
We simulated mode...
Similar publications
Background:
Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/L1) inhibitor is a promising therapeutic option that can be used as either a first-line or second-line treatment for driver-negative advanced or metastatic squamous non-small cell lung cancers (sqNSCLC). However, reuse of PD-1/L1 inhibitor in second-line beyond progre...
